Hyponatremia Treatment Guidelines — Have They Gone Too Far?
NEJM Evidence · 2023
DOI: 10.1056/evide2300014 ↗Kurz gefasst
Editorial in der Zeitschrift NEJM Evidence, 2023. Verfasst von Juan C Ayus und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension and Kidney Transplantation, University of California Irvine, Orange, CA. Hauptthemen laut MEDLINE: Hyponatremia, Brain Diseases, Metabolic, Brain Injuries. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Hyponatremia is a common electrolyte abnormality affecting hospitalized patients.1 It is an independent predictor for mortality and is associated with increased length of hospital stay and higher costs. The most serious potential complication is hyponatremic encephalopathy, a medical emergency that can result in death or irreversible brain injury if inadequately treated.2 Hypertonic saline is a safe and effective means of correcting hyponatremia.2-4 A rare yet serious complication from excessive correction of chronic hyponatremia is the development of cerebral demyelination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Nephrology and Hypertension and Kidney Transplantation, University of California Irvine, Orange, CA.
- Division of Nephrology, Department of Pediatrics, University of Pittsburgh School of Medicine and UPMC Children's Hospital of Pittsburgh, Pittsburgh.
Zitieren
APA
Ayus, J. C., & Moritz, M. L. (2023). Hyponatremia Treatment Guidelines — Have They Gone Too Far?. NEJM Evidence. https://doi.org/10.1056/evide2300014
Vancouver
Ayus JC, Moritz ML. Hyponatremia Treatment Guidelines — Have They Gone Too Far?. NEJM Evidence. 2023. doi:10.1056/evide2300014
BibTeX
@article{Ayus2023,
author = {Ayus, Juan C and Moritz, Michael L},
title = {Hyponatremia Treatment Guidelines — Have They Gone Too Far?},
journal = {NEJM Evidence},
year = {2023},
doi = {10.1056/evide2300014}
}
EUVIMED